✦ LIBER ✦

Zoledronic acid effective for bone loss in men receiving HAART

Book ID: 120847165
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715920-00050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid reduces bone loss in men

Zoledronic acid reduces bone loss in men with prostate cancer receiving goserelin

✍ R. Casey; W. Love; C. Mendoza; D. Reymond; M. Zarenda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Zoledronic acid to prevent bone loss in

Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer

✍ Chi-hang YEE; Chi-fai NG; Annie YF WONG; Chi-kowk CHAN; See-ming HOU; Sidney KH 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Zoledronic acid cost effective in preven

Zoledronic acid cost effective in preventing AI-associated bone loss

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Randomized Controlled Trial of Zoledroni

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ SMITH, MATTHEW R.; EASTHAM, JAMES; GLEASON, DONALD M.; SHASHA, DANIEL; TCHEKMEDY 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 106 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 64 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ Pitts, W. Reid 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 57 KB